Skip to main content

Cigna vs UnitedHealth: Revenue, Profit and Business Model

Cigna had $274.9B of annual revenue in FY2025. UnitedHealth had $447.6B of annual revenue in FY2025 and $12.1B of net income.

Latest financial snapshot

Cigna

Latest annual revenue
$274.9B (FY2025)
Net income
Unavailable here
Net margin
—
Revenue growth
+23.9% a year, FY2016–FY2025

UnitedHealth

Latest annual revenue
$447.6B (FY2025)
Net income
$12.1B
Net margin
2.7%
Revenue growth
+10.3% a year, FY2016–FY2025

Financial summary

Cigna

Revenue grew from $160.4 billion in 2020 to $274.9 billion in 2025, largely from Evernorth pharmacy volume, specialty drugs and new PBM clients. 2025 shareholders' net income was $6.0 billion ($22.18 per share), up from $3.4 billion in 2024, when results included a $2.7 billion after-tax loss on the VillageMD investment. Adjusted income from operations was $8.0 billion ($29.84 per share) in 2025. In the first half of 2026 Cigna reported $140.2 billion in revenue and $3.3 billion in shareholders' net income, and it raised 2026 adjusted EPS guidance to at least $30.45. The quarterly dividend was raised to $1.56 per share in February 2026.

UnitedHealth

UnitedHealth Group grew 2025 revenue 12% to $447.6 billion, yet earnings from operations fell from $32.3 billion in 2024 to $19.0 billion as Medicare Advantage and Optum Health medical costs ran well above pricing. Net margin was 2.7% and operating cash flow was $19.7 billion. 2026 is a repair year: management guided to more than $439 billion in revenue, a slight decline from planned right-sizing of membership, and after a Q2 with $112.0 billion revenue, $8.0 billion operating earnings and an 86.7% adjusted medical care ratio, raised adjusted EPS guidance to $19.50 to $20.00.

Revenue and profit by year

Cigna

Cigna revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$274.9B——+11.2%Source
FY2024$247.1B——+26.6%Source
FY2023$195.3B——+8.2%Source
FY2022$180.5B——+3.7%Source
FY2021$174.1B——+8.5%Source
FY2020$160.4B——+4.5%Source
FY2019$153.6B——+215.7%Source
FY2018$48.6B——+16.4%Source
FY2017$41.8B——+4.9%Source
FY2016$39.8B———Source
Full Cigna financials

UnitedHealth

UnitedHealth revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$447.6B$12.1B2.7%+11.8%Source
FY2024$400.3B$14.4B3.6%+7.7%Source
FY2023$371.6B$22.4B6.0%+14.6%Source
FY2022$324.2B$20.1B6.2%+12.7%Source
FY2021$287.6B$17.3B6.0%+11.8%Source
FY2020$257.1B$15.4B6.0%+6.2%Source
FY2019$242.2B$13.8B5.7%+7.0%Source
FY2018$226.2B$12B5.3%+12.5%Source
FY2017$201.2B$10.6B5.2%+8.8%Source
FY2016$184.8B$7B3.8%—Source
Full UnitedHealth financials

Where the revenue comes from

Cigna

  • Evernorth Health Services

    Majority of revenue

    Pharmacy benefit services, home delivery and Accredo specialty pharmacy dispensing, plus eviCore and MDLive care services.

  • Cigna Healthcare (U.S.)

    Second-largest

    Premiums from insured employer and individual plans and stop-loss, plus administrative fees from self-funded employers.

  • International Health

    Smaller share

    Health benefits for multinational employers and globally mobile individuals.

UnitedHealth

  • Insurance premiums
  • Administrative services fees
  • Medicare Advantage
  • Medicaid managed care
  • Optum Rx pharmacy benefit management
  • Optum Health care delivery
  • Optum Insight data and technology

Business model and strategy

Cigna

How it makes money

Cigna makes money in two ways. Evernorth Health Services, the larger business by revenue, runs Express Scripts pharmacy benefit management, Accredo specialty pharmacy, home-delivery pharmacy, eviCore utilization management and MDLive virtual care; it earns dispensing margins, administrative and service fees, and purchasing economics on prescription drugs for health plans and employers.

Growth strategy

Cigna's growth plan centers on Evernorth: winning PBM clients with the rebate-free and transparent pricing models, growing Accredo specialty pharmacy and biosimilar programs, and selling services such as EncircleRx for GLP-1 cost management and Embarc Benefit Protection for gene therapies to other health plans and employers.

Competitive advantage

Cigna's edge is scale in pharmacy plus a capital-light medical business. Evernorth managed about 118 million pharmacy customers at June 30, 2026, giving it purchasing power with drug makers and pharmacies, and Accredo is one of the largest U.S. specialty pharmacies.

Cigna business model in full

UnitedHealth

How it makes money

UnitedHealth Group Incorporated is the world's largest healthcare company by revenue, operating a diversified enterprise model that integrates commercial health insurance with comprehensive healthcare delivery and data analytics. The business functions through two distinct, complementary platforms: UnitedHealthcare and Optum.

Growth strategy

UnitedHealth is focused on pricing and benefit design, medical cost management, Medicare Advantage discipline, Medicaid and employer offerings, Optum Rx scale, Optum Health care delivery, technology, data analytics, and value-based care capabilities.

Competitive advantage

UnitedHealth Group's insurmountable economic moat is derived from its closed-loop healthcare flywheel connecting health insurance risk pooling directly with clinical service delivery.

UnitedHealth business model in full

Questions about Cigna vs UnitedHealth

Which company has higher revenue — The Cigna Group or UnitedHealth Group Incorporated?

The Cigna Group had $274.9B (FY2025), while UnitedHealth Group Incorporated had $447.6B (FY2025). By latest annual revenue, UnitedHealth Group Incorporated is the larger business, with The Cigna Group showing a smaller revenue base.

What is the market cap of The Cigna Group vs UnitedHealth Group Incorporated?

The Cigna Group's market capitalisation stands at $71.9B, while UnitedHealth Group Incorporated's is $450.0B. UnitedHealth Group Incorporated carries the higher market valuation, reflecting investors' expectations of its future earnings power relative to The Cigna Group.

How does revenue per employee compare for The Cigna Group and UnitedHealth Group Incorporated?

The Cigna Group has $4.06M / employee in revenue per employee, while UnitedHealth Group Incorporated has $1.15M / employee. Headcounts may use different dates, so the ratio alone does not establish which business operates more efficiently.

How do The Cigna Group and UnitedHealth Group Incorporated make money?

The Cigna Group and UnitedHealth Group Incorporated generate revenue in fundamentally different ways. The Cigna Group: Cigna makes money in two ways. UnitedHealth Group Incorporated: UnitedHealth Group Incorporated is the world's largest healthcare company by revenue, operating a diversified enterprise model that integrates commercial health insurance with comprehensive healthcare delivery and data analytics.

Which company is valued higher relative to revenue — The Cigna Group or UnitedHealth Group Incorporated?

On a price-to-sales (P/S) basis, The Cigna Group trades at 0.3x P/S and UnitedHealth Group Incorporated at 1.0x P/S. UnitedHealth Group Incorporated commands a higher revenue multiple, typically indicating that investors expect faster growth or higher future margins compared to The Cigna Group. A higher multiple is not inherently better — it may also signal that the stock is priced for perfection.

Is The Cigna Group bigger than UnitedHealth Group Incorporated?

By last reported revenue, UnitedHealth Group Incorporated ($447.6B (FY2025)) is the larger company compared to The Cigna Group ($274.9B (FY2025)). Revenue scale is one dimension of size — market capitalisation, employee count, and geographic reach are also relevant depending on the context.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Cigna vs UnitedHealth overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.